Aleafia Health

Aleafia Health FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Aleafia Health (AH.TO) as of Nov 22, 2026 is 14.83 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 12.13 % — a change of 22.28% (higher).

FCF Conversion

14.83 %

YoY

22.28%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Aleafia Health is 2023 14.83 % . FCF Conversion Rate (FCF/EBITDA) of Aleafia Health was 2022 12.13 % . It decreases by 22.28% higher compared to the previous year.

The Aleafia Health FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2016
98.15 CAD
Jan 1, 2017
13.70 CAD
Jan 1, 2018
121.09 CAD
Jan 1, 2019
118.50 CAD
Jan 1, 2020
10.28 CAD
Jan 1, 2021
22.13 CAD
Jan 1, 2022
12.13 CAD
Jan 1, 2023
14.83 CAD
The Aleafia Health FCF Conversion history
YEARFCF ConversionYoY
14.83 %+22.28%
12.13 %-45.20%
22.13 %+115.34%
10.28 %-91.33%
118.50 %-2.14%
121.09 %+783.85%
13.70 %-86.04%
98.15 %-84.97%
653.01 %+2,284.66%
27.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aleafia Health Stock analysis

What does Aleafia Health do? Aleafia Health Inc is a company that operates in the health sector. It was founded in 2017 and is headquartered in Vaughan, Ontario, Canada. The founders of Aleafia Health were involved in the medical sector and saw the growing demand for cannabis products. They recognized that there was an opportunity to meet market demand while also providing people with a legal and safe way to access medical cannabis. Aleafia Health focuses on the supply of medical cannabis to provide its customers with the best and safest product. They pursue a vertically integrated business model that focuses on the entire supply chain of medical cannabis. The company includes cultivation, processing, manufacturing, and distribution of medical cannabis, as well as the establishment of patient portals to connect patients and offer them a comprehensive range of services. Aleafia Health also has a strong presence in the field of medical research on the cannabis plant. The company is constantly searching for new types of medical cannabis to offer its patients a wider range of options. The company is divided into several divisions. The main division of Aleafia Health is the production and retail of medical cannabis products. The company is a fully integrated provider of medical cannabis that manages all aspects of the supply chain from cultivation to end-consumer sales. Another division of Aleafia Health is the mobile clinic division. This is a mobile medical and nursing service that provides medical cannabis care and clinical nutrition counseling to patients throughout Canada. The company also has its own pharmacy distribution and supply division, which operates in accordance with Canadian regulations and distributes medical cannabis to pharmacies and medical practices. Aleafia Health also has its own division for medical research, which focuses on the research and development of new types of medical cannabis. The company has established strong partnerships with universities and research institutions to raise awareness of medical cannabis and investigate the effectiveness of cannabis in the treatment of various diseases and conditions. The company produces a wide range of medical cannabis products, including concentrated formulations, vaporizer devices, and topicals specifically designed for use in various physical ailments. As a company in the health sector, Aleafia Health pays special attention to ensuring that its products and services meet the highest standards of quality and safety. The company has a responsibility to its customers and society to ensure that its products and services are safe and effective. Overall, Aleafia Health is a leading provider of medical cannabis and has a strong presence in the market. The company is vertically integrated and has various divisions that are all focused on the supply chain of the medical cannabis market. Aleafia Health is committed to producing innovative medical cannabis products while meeting the highest standards of safety and effectiveness. Aleafia Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aleafia Health stock

FCF Conversion Rate (FCF/EBITDA) of Aleafia Health is 14.83 % in 2023.

FCF Conversion Rate (FCF/EBITDA) of Aleafia Health changed from 12.13 % to 14.83 %, representing a 22.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Aleafia Health since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Aleafia Health with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Aleafia Health

All Key Metrics — Aleafia Health